Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (GZPHF)

2.34 0.00 (0.00%) USD  |  OTCM  |  Sep 03, 16:00
More

Guangzhou Baiyunshan Pharmaceutical Holdings Price : 2.34 for Sept. 3, 2026

Price Chart

View Price for GZPHF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Chart
Start Trial

Historical Price Data

View and export this data back to 2006. Start Trial.
Date Open High Low Close Volume
Sep 03, 2026 2.34 2.34 2.34 2.34 0.000
Sep 02, 2026 2.34 2.34 2.34 2.34 0.000
Sep 01, 2026 2.34 2.34 2.34 2.34 0.000
Aug 31, 2026 2.34 2.34 2.34 2.34 0.000
Aug 28, 2026 2.34 2.34 2.34 2.34 0.000
Aug 27, 2026 2.34 2.34 2.34 2.34 0.000
Aug 26, 2026 2.34 2.34 2.34 2.34 0.000
Aug 25, 2026 2.34 2.34 2.34 2.34 0.000
Aug 24, 2026 2.34 2.34 2.34 2.34 0.000
Aug 21, 2026 2.34 2.34 2.34 2.34 0.000
Aug 20, 2026 2.34 2.34 2.34 2.34 0.000
Aug 19, 2026 2.34 2.34 2.34 2.34 0.000
Aug 18, 2026 2.34 2.34 2.34 2.34 0.000
Aug 17, 2026 2.34 2.34 2.34 2.34 0.000
Aug 14, 2026 2.34 2.34 2.34 2.34 0.000
Aug 13, 2026 2.34 2.34 2.34 2.34 0.000
Aug 12, 2026 2.34 2.34 2.34 2.34 0.000
Aug 11, 2026 2.34 2.34 2.34 2.34 0.000
Aug 10, 2026 2.34 2.34 2.34 2.34 0.000
Aug 07, 2026 2.34 2.34 2.34 2.34 0.000
Aug 06, 2026 2.34 2.34 2.34 2.34 0.000
Aug 05, 2026 2.34 2.34 2.34 2.34 0.000
Aug 04, 2026 2.34 2.34 2.34 2.34 0.000
Aug 03, 2026 2.34 2.34 2.34 2.34 0.000
Jul 31, 2026 2.34 2.34 2.34 2.34 0.000

Price Definition

The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).

Read full definition.

Price Range, Past 5 Years

View Price Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Benchmarks

View Price Benchmarks
Start Trial
Sinopharm Group Co., Ltd. 9.83
PomDoctor Ltd. 0.8395
Cencora, Inc. 330.97
Cardinal Health, Inc. 247.14
McKesson Corp. 906.78

Price Related Metrics

PE Ratio 10.33
PS Ratio 0.3412
Price to Book Value 0.6597
Price to Free Cash Flow 12.43
Earnings Yield 9.68%
Market Cap 3.804B
Operating PE Ratio 9.279
Normalized PE Ratio 10.25